Margaret A Horn Revolution Medicines, Inc. (RVMD) insider trading activity

Margaret A Horn is Chief Operating Officer of Revolution Medicines, Inc.. Currently has a direct ownership of 139,553 shares of RVMD, which is worth approximately $5.35 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 2,914 shares (Common Stock) at a price of $31.58 per share, resulting in proceeds of $92,024. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

2.05% 3M change

39.47% 12M change

Total Value Held $5.35 Million

Margaret A Horn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Open market or private sale	$92,024 $31.58 p/Share	2,914 Reduced 2.05%	139,553 Common Stock
Mar 12 2024	SELL Open market or private sale	$270,379 $34.07 p/Share	7,936 Reduced 5.28%	142,467 Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$32,458 $4.09 p/Share	7,936 Added 5.01%	150,403 Common Stock
Mar 11 2024	SELL Open market or private sale	$535,304 $34.02 p/Share	15,735 Reduced 9.95%	142,467 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$64,356 $4.09 p/Share	15,735 Added 9.05%	158,202 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	41,000 Added 22.35%	142,467 Common Stock
Dec 18 2023	SELL Open market or private sale	$77,518 $25.9 p/Share	2,993 Reduced 2.87%	101,467 Common Stock

Dec 15 2023	SELL Open market or private sale	$133,200 $26.64 p/Share	5,000 Reduced 4.57%	104,460 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.37%	109,460 Common Stock
Dec 06 2023	SELL Open market or private sale	$125,000 $25.0 p/Share	5,000 Reduced 4.57%	104,460 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.37%	109,460 Common Stock
Oct 25 2023	BUY Exercise of conversion of derivative security	$4,050 $0.54 p/Share	7,500 Added 6.7%	104,460 Common Stock
Oct 16 2023	SELL Open market or private sale	$821,749 $32.87 p/Share	25,000 Reduced 20.5%	96,960 Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	$102,250 $4.09 p/Share	25,000 Added 17.01%	121,960 Common Stock
Sep 18 2023	SELL Open market or private sale	$78,713 $31.31 p/Share	2,514 Reduced 2.53%	96,960 Common Stock
Sep 15 2023	SELL Open market or private sale	$160,400 $32.08 p/Share	5,000 Reduced 4.79%	99,474 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.57%	104,474 Common Stock
Aug 31 2023	SELL Open market or private sale	$340,500 $34.05 p/Share	10,000 Reduced 9.13%	99,474 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	$40,900 $4.09 p/Share	10,000 Added 8.37%	109,474 Common Stock
Aug 15 2023	SELL Open market or private sale	$152,900 $30.58 p/Share	5,000 Reduced 4.79%	99,474 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$20,450 $4.09 p/Share	5,000 Added 4.57%	104,474 Common Stock
Jun 20 2023	SELL Open market or private sale	$52,318 $24.89 p/Share	2,102 Reduced 2.07%	99,474 Common Stock
Mar 17 2023	SELL Open market or private sale	$26,789 $21.78 p/Share	1,230 Reduced 1.21%	100,062 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	40,000 Added 28.31%	101,292 Common Stock
Dec 19 2022	SELL Open market or private sale	$27,986 $22.94 p/Share	1,220 Reduced 1.95%	61,292 Common Stock

Also insider at

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

Director

MAH

Margaret A Horn

Chief Operating Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account